Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - INNOVUS PHARMACEUTICALS, INC. | Financial_Report.xls |
| EX-32.1 - EXHIBIT 32.1 - INNOVUS PHARMACEUTICALS, INC. | v325919_ex32-1.htm |
| EX-31.2 - EXHIBIT 31.2 - INNOVUS PHARMACEUTICALS, INC. | v325919_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - INNOVUS PHARMACEUTICALS, INC. | v325919_ex31-1.htm |
| 10-Q - FORM 10-Q - INNOVUS PHARMACEUTICALS, INC. | v325919_10q.htm |
EXHIBIT 32.2
Section 1350 Certification
In connection with the Annual Report of Innovus Pharmaceuticals, Inc. (the “Company”) on Form 10-Q for the three months ended September 30, 2012, as filed with the Securities and Exchange Commission (the “Report”), I, Vivian Liu, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. SS. 1350, as adopted pursuant to SS. 906 of the Sarbanes-Oxley Act of 2002, that:
| 1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and |
| 2. | The information contained in the Report fairly presents, in all material respects, the financial conditions and results of operations of the Company. |
| October 24, 2012 |
/s/Vivian Liu, Vivian Liu, Chief Financial Officer |